Sensio Air

Drug Discovery AI · Artificial Intelligence

Overview

Sensio Air is a leading TechBio AI company using Large Particle Models and patented technologies to identify airborne pathogens in real-time.

Funding and backers

Team
11-50
employees, estimated range
Backers
1
StartX
Momentum
0/100
no fresh signals
Backed byfrom the funds' portfolios and accelerator catalogs
StartX accelerator
Investors in similar startupsfunds that back the companies most like this one
Hitachi Ventures
backs Relation Therapeutics, Cure51
Y Combinator
backs Cellbyte
Andreessen Horowitz
backs Inceptive
Plug and Play
backs CardiaTec Biosciences
Soma Capital
backs Cellbyte
DCVC
backs Relation Therapeutics
Similar startupsby what they do, their industry and backers
CardiaTec BiosciencesVenture round · 2 yr ago
CardiaTec is a TechBio company leveraging large scale multiomics data to discover novel cardiovascular therapeutics.
Relation TherapeuticsVenture round · 17 mo ago · Founded 2019 · 51-200 employees · 9 roles
Relation Therapeutics is a London biotechnology company founded in 2019 that applies graph machine learning to disease biology. Its…
Gordian BiotechnologyFounded 2018 · 51-200 employees · 7 roles
Gordian Biotechnology is a biotechnology company that generates in vivo perturbation data across more than 1000 targets in diseases such as…
Cure51Seed $16.2M · 2 yr ago · Founded 2022
Cure51 collects and analyses the biological data of exceptional cancer survivors to find what made their outcome possible. Its platform…
DeepSynergy.AI11-50 employees · 1 role
DeepSynergy.AI is a German software company that builds an AI-based tool for complex production planning in manufacturing. It offers…
CellbyteSeed $2.8M · 11 mo ago · 11-50 employees · 4 roles
AI Agents for Pharmaceutical Drug Launches. Pricing & Market Access professionals use Cellbyte to receive answers in seconds instead of…